Susan B. Washer - 01 Nov 2021 Form 4 Insider Report for APPLIED GENETIC TECHNOLOGIES CORP

Role
President and CEO, Director
Signature
/s/ Stacie Aarestad, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Nov 2021
Net transactions value
+$13,570
Form type
4
Filing time
03 Nov 2021, 19:19:28 UTC
Previous filing
29 Jul 2021
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGTC Common Stock Options Exercise $13,570 +3,877 +14% $3.50 32,285 01 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGTC Stock Option (right to buy) Options Exercise $0 -3,877 -100% $0.000000* 0 01 Nov 2021 Common Stock 3,877 $3.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option is fully-vested and was exercisable for shares of common stock at any time until the expiration of the option at the holder's election.